{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:11:49Z","timestamp":1793398309556,"version":"4.5.0"},"reference-count":18,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1177\/03331024261420835","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:39:02Z","timestamp":1773394742000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["WHO's essential medicines list: Additions for migraine and cluster headache"],"prefix":"10.1177","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-2113","authenticated-orcid":false,"given":"Cristina","family":"Tassorelli","sequence":"first","affiliation":[{"name":"Department of Brain and Behavioral Science, University of Pavia, Pavia, Italy"},{"name":"IRCCS Mondino Foundation, Headache Science and Rehabilitation Unit, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lampl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Konventhospital Barmherzige Br\u00fcder, Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-4049","authenticated-orcid":false,"given":"Massimo","family":"Leone","sequence":"additional","affiliation":[{"name":"Community of Sant\u2019Egidio"},{"name":"Global Neurology Program, International Affairs, IRCCS C. Besta Neurologic Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[{"name":"Erasmus MC University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-1905","authenticated-orcid":false,"given":"Mario FP","family":"Peres","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, HCFMUSP, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4702","authenticated-orcid":false,"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[{"name":"Headache Unit, Neurology Department, Hospital Universitari Vall d\u2019Hebron & Headache & Neurological Pain Research Group, Vall d\u2019Hebron Institute of Research, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1933-4049","authenticated-orcid":false,"given":"Francesca","family":"Puledda","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology and Neuroscience, King's College London"},{"name":"NIHR King's Clinical Research Facility, SLaM Biomedical Research Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-1939","authenticated-orcid":false,"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[{"name":"University of L'Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tinelli","sequence":"additional","affiliation":[{"name":"The London School of Economics and Political Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-5017","authenticated-orcid":false,"given":"Derya","family":"Ulud\u00fcz","sequence":"additional","affiliation":[{"name":"Neurology Department, Cerrahpa\u015fa School of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Steiner","sequence":"additional","affiliation":[{"name":"NorHead, Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"University of Copenhagen"},{"name":"Department of Brain Sciences, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"93","article-title":"Essential medicines for neurological disorders: updates, rejections, and the road ahead","volume":"24","author":"Editorial","year":"2025","unstructured":"Editorial. Essential medicines for neurological disorders: updates, rejections, and the road ahead. Lancet Neurol 2025; 24: 93.","journal-title":"Lancet Neurol"},{"key":"e_1_3_3_3_2","unstructured":"https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/25th-expert-committee-on-selection-and-use-of-essential-medicines (accessed Nov 12 2025)."},{"key":"e_1_3_3_4_2","unstructured":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/ae7a80b7-cec6-456b-8ad7-f0ad4e335c55\/content (accessed Nov 12 2025)."},{"key":"e_1_3_3_5_2","unstructured":"https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/25th-expert-committee-on-selection-and-use-of-essential-medicines\/i.7-ibuprofen-acute-treatment-of-migraine (accessed Nov 12 2025)."},{"key":"e_1_3_3_6_2","unstructured":"https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/25th-expert-committee-on-selection-and-use-of-essential-medicines\/a.10-eletriptan\u2013naproxen-migraine (accessed Nov 12 2025)."},{"key":"e_1_3_3_7_2","unstructured":"https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/25th-expert-committee-on-selection-and-use-of-essential-medicines\/i10-prednisolone-sumatriptan-and-verapamil-cluster-headache (accessed Nov 12 2025)."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7086"},{"key":"e_1_3_3_9_2","first-page":"108","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for cardiovascular pharmacotherapy of the European Society of Cardiology","volume":"2","author":"Schmidt M","year":"2016","unstructured":"Schmidt M, Lamberts M, Olsen A-MS, et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for cardiovascular pharmacotherapy of the European Society of Cardiology. Eur Heart J 2016; 2: 108\u2013118.","journal-title":"Eur Heart J"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2022.08.006"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0521-8"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16434"},{"key":"e_1_3_3_13_2","unstructured":"https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/25th-expert-committee-on-selection-and-use-of-essential-medicines\/a.13-fremanezumab-high-frequency-and-chronic-migraine (accessed Nov 12 2025)."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01128-0"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2021.1940672"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024211053571"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.15045"},{"key":"e_1_3_3_18_2","volume-title":"Fremanezumab for preventing migraine: Cost-effectiveness estimates","author":"National Institute for Health and Care Excellence","year":"2022","unstructured":"National Institute for Health and Care Excellence. Fremanezumab for preventing migraine: Cost-effectiveness estimates. Manchester, UK : NICE, 2022, Available at: https:\/\/www.nice.org.uk\/guidance\/ta764\/chapter\/3-Committee-discussion#cost-effectiveness-estimates (accessed Nov 12 2025)."},{"key":"e_1_3_3_19_2","volume-title":"Global status report on neurology","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Global status report on neurology. Geneva: WHO, 2025, Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240116139 (accessed Nov 12 2025)."}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024261420835","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03331024261420835","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024261420835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:44:20Z","timestamp":1777387460000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03331024261420835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/03331024261420835"],"URL":"https:\/\/doi.org\/10.1177\/03331024261420835","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"article-number":"03331024261420835"}}